The evaluation of the reproducibility in assessing PD-L1 TPS and CPS using single PD-L1 IHC (S-IHC) but also using a more original dual IHC (D-IHC) method combining PD-L1 IHC with tumor nuclear marker IHC is the aim of the present study. The gene discussed is CD274; the disease is neoplasm.